HEALEY ALS Platform Trial Research Partners
For Industry/Pharma with ALS Pipeline
The HEALEY ALS Platform Trial will keep adding treatment arms. To learn more, pharma companies with a therapy for ALS can contact us via email.
Pioneering Breakthroughs Together

Collaboration is the key to our success. We believe sharing knowledge and expertise are essential to rapidly bringing innovative therapies to patients. That’s why we are partnering with leading industry and academic institutions to launch the first platform trial for ALS and share information with our peers to accelerate therapeutic innovation. To join us, email HEALEYALSPlatform@mgh.harvard.edu.
Industry Partnerships
Academic Partnerships
Our commitment to advancing treatment and therapies for individuals with ALS encourages us to the constant pursuit of new research partnerships and collaborations. We look forward to sharing our progress as we work towards our goal: to find a cure for ALS. We can do this together!
Investigator Resources
Learn more ways to partner with us in the collaborative HEALEY ALS Platform Trial.HEALEY ALS Platform Trial Publication Policy
HEALEY ALS Platform Trial Ancillary Study Policy
Support the Sean M. Healey and AMG Center for ALS
Your support helps us provide excellent patient care today, and expands the boundaries of what will be possible in the future.
Platform Trial Presentation
View slides from a presentation at the 30th International Symposium on ALS/MND in Perth, Australia on December 6, 2019.
Join Our Quest
Join these people and organizations in supporting our quest to find a cure for ALS.